Difference between revisions of "DCE MRI Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
(86 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
{{TOCright}}
 
{{TOCright}}
 
:Co-chairs: Caroline Chung, MD; Hendrik Laue, PhD
 
:Co-chairs: Caroline Chung, MD; Hendrik Laue, PhD
:Secretary: Susan Stanfa
+
:RSNA Staff Support: Susan Stanfa
* [http://tinyurl.com/QIBA-DCE-MRI-Roster Roster]
+
* [https://docs.google.com/spreadsheets/d/e/2PACX-1vRzQYPdYm51Ak3VYii84CtIDFiYRIylH2IkHQZxdAAjJTAVX4iRqlGl2tety1pnDFKN9kLxoKI-RcoM/pubhtml?gid=1048658726&single=true Roster]
  
  
Line 11: Line 11:
 
*[[Synthetic DCE-MRI Data]]
 
*[[Synthetic DCE-MRI Data]]
  
==Recent DCE MRI Meetings==
 
  
'''Approved call summaries:'''
+
==DCE MRI Meetings==
 +
Biweekly Zomm meetings, 2nd and 4th Mondays of each month @ 11am-12pm Central Time (Contact [mailto:qiba@rsna.org qiba@rsna.org] for details)
  
*[[Media:2019_02-04_QIBA_DCE_Biomarker_Cmte_Call_Summary-FINAL.pdf|February 4, 2019]]
+
'''Recently Approved Call Summaries'''
*[[Media:2019_01-07_QIBA_DCE_Biomarker_Cmte_Call_Summary-FINAL.pdf|January 7, 2019]]
+
*[[Media:2021_10-25_QIBA_DCE-MRI_BC_Call_Summary-FINAL.pdf|October 25, 2021]]
*[[Media:2018_11-12_QIBA_DCE_Biomarker_Cmte_Call_Summary-FINAL.pdf|November 12, 2018]]
+
*[[Media:2021_10-11_QIBA_DCE-MRI_BC_Call_Summary-FINAL.pdf|October 11, 2021]]
 +
*[[Media:2021_09-27_QIBA_DCE-MRI_BC_Call_Summary-FINAL-2.pdf|September 27, 2021]]
  
 
'''''[[DCE-MRI BC Call Summaries Archive]]'''''
 
'''''[[DCE-MRI BC Call Summaries Archive]]'''''
 
+
<br />
[[QIBA DCE-MRI Technical Committee Call Summaries]]
+
<br />
 +
* [[QIBA DCE-MRI Technical Committee Call Summaries|DCE-MRI TC Call Summaries Archive 2008-2012]]
 +
* Earlier materials can be found on the [[Perfusion, Diffusion and Flow-MRI tech ctte|PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee]] page
  
 
==Profile Development==
 
==Profile Development==
Line 32: Line 35:
 
*[[Tools and recommendation for structured literature review]]
 
*[[Tools and recommendation for structured literature review]]
 
*[[Archived DCE-MRI Profiles]]
 
*[[Archived DCE-MRI Profiles]]
 
  
 
==Reference Materials==
 
==Reference Materials==
Line 45: Line 47:
 
*[[Proposed Changes to Acquisition Protocol -- 20090315 - E Jackson‎]]
 
*[[Proposed Changes to Acquisition Protocol -- 20090315 - E Jackson‎]]
  
==Round 1 of QIBA Funded Projects==
 
  
 +
==QIBA Funded Projects==
 +
 +
====Round 1====
 
*[[VirtualScopics, Inc.]]
 
*[[VirtualScopics, Inc.]]
 
**[[Media:DrJackson QIBA Phantom 09203 AMR3.pdf|Example RSNA DCE-MRI Phantom Data Analysis Report]]
 
**[[Media:DrJackson QIBA Phantom 09203 AMR3.pdf|Example RSNA DCE-MRI Phantom Data Analysis Report]]
Line 53: Line 57:
 
*[[The University of Texas M.D. Anderson Cancer Center]]
 
*[[The University of Texas M.D. Anderson Cancer Center]]
  
 +
====Round 2====
  
==Round 2 of QIBA Funded Projects==
+
*[[Media:4-UPenn-Test-Retest.-Yr2.pdf|Test-Retest Evaluation of Repeatability of DCE-MRI and DWI in Human Subjects]]
  
*[[Media:4-UPenn-Test-Retest.-Yr2.pdf|Test-Retest Evaluation of Repeatability of DCE-MRI and DWI in Human Subjects]]
+
====Round 3====
 +
 
 +
*[[QIBA Artificial Data Evaluation Software]]
 +
 
 +
*[[Media:Development of a Tool to Evaluate Software using Artificial DCE-MRI Data and Statistical Analysis.pdf|Project (J) Development of a Tool to Evaluate Software using Artificial DCE-MRI Data and Statistical Analysis (Fraunhofer MEVIS, Germany)]]
 +
 
 +
*[[Media:DCE-MRI Phantom Study to Evaluate the Impact of Parallel Imaging and B1 In-homogeneities at Different MR Field Strengths of 1.0T, 1.5T, and 3.0T.pdf | Project (H) DCE-MRI Phantom Study to Evaluate the Impact of Parallel Imaging and B1 In-homogeneities at Different MR Field Strengths of 1.0T, 1.5T, and 3.0T (University Hospital Cologne, Germany)]]
 +
 
 +
====Round 4====
 +
 
 +
*[[Media:Digital Reference Object for DCE-MRI Analysis Software Verification.pdf|Project (AA) Digital Reference Object for DCE-MRI Analysis Software Verification (Cleveland Clinic Foundation)]]
 +
 
 +
*[[Media:DRO for DCE-MRI Analysis Software Verification.pdf|Project (T) Digital Reference Object for DCE-MRI Analysis Software Verification 2 (Duke University)]]
  
 +
*[[Media:RSNA DCE-MRI Phantom Automated Analysis Software Package Development.pdf|Project (U) RSNA DCE-MRI Phantom Automated Analysis Software Package Development (University of Wisconsin)]]
  
==Round 3 of QIBA Funded Projects==
+
====Round 5====
 +
*[[Media:Aggregated Measures of Agreement for QIB Validation-An Open Source Toolkit.pdf | Project (K) Aggregated Measures of Agreement for QIB Validation-An Open Source Toolkit (Duke University)]]
  
*[[QIBA Artificial Data Evaluation Software]]
+
====Round 6====
 +
*[[Media:Evaluation of RF Transmit Calibration Options for Quantitative DCE-MRI.pdf | Project (Z) Evaluation of RF Transmit Calibration Options for Quantitative DCE-MRI (University of Southern California)]]
  
 
==Historical Background - Formation of the Group==
 
==Historical Background - Formation of the Group==

Revision as of 01:08, 25 November 2021

Co-chairs: Caroline Chung, MD; Hendrik Laue, PhD
RSNA Staff Support: Susan Stanfa


Project Snapshot

Develop a quantitative imaging profile for Dynamic Contrast Enhanced MRI.


DCE MRI Meetings

Biweekly Zomm meetings, 2nd and 4th Mondays of each month @ 11am-12pm Central Time (Contact qiba@rsna.org for details)

Recently Approved Call Summaries

DCE-MRI BC Call Summaries Archive

Profile Development

Reference Materials


QIBA Funded Projects

Round 1

Round 2

Round 3

Round 4

Round 5

Round 6

Historical Background - Formation of the Group